Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 205-216 of 9489

Business Wire logo

Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer

PR Newswire associated0

Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

Business Wire logo

Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results

Business Wire logo

Almirall H1 2026 Results

GlobeNewswire associated0

Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare

Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A.

U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline

Business Wire logo

Norway’s health system adopts Wolters Kluwer UpToDate Enterprise Edition

Synaptiq Therapeutics Launches with Acquisition of Clinical-Stage SYN-001 Program

PR Newswire associated0

Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer

PR Newswire associated0

PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS

Business Wire logo

Azafaros Completes Enrollment of Phase 3 (NAVIGATE) Study Evaluating Nizubaglustat for the Treatment of Patients with GM1/GM2 Gangliosidoses

FAMAR appoints Bruce Vielle as Chief Executive Officer

  • Prev Page
  • 1
  • 2
  • …
  • 17
  • 18
  • 19
  • …
  • 790
  • 791
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us